ReviewThe Journal of infectious diseases2024

The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review.

Anthony M Marchese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.